高级别胶质瘤中程序性死亡配体1表达的影像学与预后特征评估
该研究通过组织微阵列免疫组化评估71例新诊断高级别胶质瘤患者的PD-L1表达及CD4+、CD8+T细胞和CD204+巨噬细胞浸润,并行二维影像分析。PD-L1表达见于15例(21.1%),与CD4+、CD8+T细胞密度显著相关,FLAIR与强化比值在PD-L1+肿瘤中显著更高,但PD-L1表达与44例IDH野生型胶质母细胞瘤患者的中位生存时间无显著关联。
要点
- PD-L1表达见于15/71例(21.1%)新诊断高级别胶质瘤。
- PD-L1表达与CD4+、CD8+T细胞密度显著相关,与CD204+巨噬细胞密度无显著相关。
- PD-L1+肿瘤的FLAIR与强化比值显著高于PD-L1-肿瘤。
核心结论
- PD-L1表达与CD4+和CD8+T细胞浸润相关,提示PD-L1与免疫细胞间存在显著相互作用。
- PD-L1表达与FLAIR与强化比值升高呈正相关,提示影像学特征可能反映免疫状态。
- 结果不支持PD-L1对IDH野生型胶质母细胞瘤患者的预后影响。
研究设计与样本
- 研究采用组织微阵列和免疫组化分析评估PD-L1表达及肿瘤浸润CD4+、CD8+T细胞和CD204+巨噬细胞。
- 通过二维分析评估强化区域和FLAIR高信号区域。
- 对44例IDH野生型胶质母细胞瘤患者进行Kaplan-Meier分析评估总生存时间。
主要发现
- 共评估71例1998年10月至2012年4月间治疗的新诊断高级别胶质瘤患者,PD-L1表达见于15例(21.1%)。
- PD-L1表达与CD4+T细胞密度相关(p=0.025),与CD8+T细胞密度相关(p=0.0098),与CD204+巨噬细胞密度无显著相关(p=0.19)。
- FLAIR与强化比值在PD-L1+肿瘤中显著高于PD-L1-肿瘤(p=0.0037)。
- PD-L1表达与中位生存时间无显著关联(PD-L1+ vs PD-L1-:19.2 vs 14.9个月;p=0.39)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Gliomas are characterized by immunosuppressive features. Programmed death-ligand 1 (PD-L1) is overexpressed and plays an important role in the immunosuppressive tumor microenvironments of gliomas. However, the radiographical and prognostic significance of PD-L1 expression remains unclear. METHODS: Using tissue microarrays, we evaluated PD-L1 expression and the presence of tumor-infiltrating CD4+ and CD8+T cells and CD204+macrophages using immunohistochemical analysis. Contrast enhancement area and fluid-attenuated inversion recovery (FLAIR) hyperintensity area were evaluated by two-dimensional analysis. Kaplan-Meier analysis was performed to evaluate the overall survival time in 44 patients with isocitrate dehydrogenase (IDH)-wildtype glioblastoma. RESULTS: We evaluated 71 patients with newly diagnosed high-grade gliomas who were treated between October 1998 and April 2012. PD-L1 expression was observed in 15 patients (21.1%). A significant association of PD-L1 expression with the CD4+ and CD8+ T cell densities, but not with CD204+ macrophage densities, was observed (p = 0.025, p = 0.0098, and p = 0.19, respectively). The FLAIR-to-enhancement ratio was significantly higher in PD-L1+ tumors than in PD-L1- tumors (p = 0.0037). PD-L1 expression did not show a significant association with the median survival time (PD-L1 + vs. PD-L1-: 19.2 vs 14.9 months; p = 0.39). CONCLUSION: PD-L1 expression was associated with CD4+ and CD8+ T cell infiltration, indicating a significant interplay between PD-L1 and immune cells. The positive correlation of PD-L1 expression with an increased FLAIR-to-enhancement ratio suggested that radiographical characteristics could reflect the immunological status. Our results did not support the prognostic impact of PD-L1 in patients with IDH-wildtype glioblastomas.
引用
- Ohno M, Kitano S, Satomi K, et al. Assessment of radiographic and prognostic characteristics of programmed death-ligand 1 expression in high-grade gliomas. J Neurooncol. 2022. PMID: 36282354. doi:10.1007/s11060-022-04165-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。